{"id":"W2484616545","doi":"10.1182/blood-2016-02-699520","title":"Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Ozmosis Research (Canada); McGill University; Health Sciences Centre; University of British Columbia; Hôpital du Sacré-Cœur de Montréal; BC Cancer Agency; Princess Margaret Cancer Centre; Simon Fraser University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Panobinostat; Rituximab; Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Medicine; Refractory (planetary science); Cancer research; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001736242,0.001396135,0.0023953,0.0005122189,0.0002997735,0.0007144909,0.000645905,0.001059401,0.001814281],"category_scores_gemma":[0.0009178817,0.0005776742,0.0009522938,0.0003315029,0.0008173917,0.0006518277,0.0003118279,0.002142022,0.000436087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007257416,"about_ca_system_score_gemma":0.00107987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006446239,"about_ca_topic_score_gemma":0.001249734,"domain_scores_codex":[0.9994028,0.0003446701,0.00002502823,0.00009571399,0.00004502513,0.00008676999],"domain_scores_gemma":[0.9994212,0.000113489,0.00009004681,0.00006579062,0.00004085867,0.0002685227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6836929,0.1161123,0.00900721,0.00054811,0.001217251,0.0004589962,0.0003266733,0.002661319,0.08803552,0.0002468507,0.00155294,0.09613991],"study_design_scores_gemma":[0.3561401,0.6269226,0.008341487,0.00001680344,0.0002943049,0.0003084902,0.00004002592,0.00120114,0.005435185,0.0001213773,0.001155707,0.00002271189],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997067,0.0008970107,0.0002867676,0.0001635122,0.00005342872,0.0008667761,0.0002294985,0.00004476983,0.0003912245],"genre_scores_gemma":[0.9919057,0.001112107,0.001555087,0.0005691459,0.0001383182,0.002114869,0.001291167,0.00002354502,0.001289991],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0023953,"threshold_uncertainty_score":0.009182215,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01396331256451666,"score_gpt":0.2718089834546433,"score_spread":0.2578456708901266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}